01 · THE CUSTOMER PROBLEM
Bioprocessors need to recover cells or biomass without overloading downstream filtration, adding persistent flocculants or accepting poor separation economics.
Charge-controlled chitosan can aggregate cells and suspended solids into recoverable flocs while dose, pH and removal are optimized around the actual broth.
Chitosan’s positive charge can aggregate negatively charged cells and suspended solids into separable flocs.
02 · RECOMMENDED STARTING POINT
Start with the material designed for the decision.
As a bio-based process aid, chitosan can simplify clarification and biomass recovery while giving process developers control over dose, molecular specification and removal validation.
Without the shell
Controlled fungal sourcing supports a traceable, non-animal supply strategy.
Specification engineered
MW, DDA, purity, charge density and format are selected around the target result.
Application ready
Powder is only the starting point; Mykito also develops films, fibers, gels, coatings and formulations.
One technical partner
Material selection, formulation support and the validation plan are connected from the first sample.
03 · PERFORMANCE TARGETS
Build toward outcomes a buyer can measure.
Cell aggregation
Charge neutralization and polymer bridging bring suspended cells together into larger, recoverable flocs.
Biomass harvesting
Chitosan can support sedimentation, filtration or flotation in microbial and algal production systems.
Clarification support
Flocculation can reduce suspended solids entering downstream filtration and separation operations.
Process integration
Dose, pH and mixing can be optimized around the organism, broth chemistry and recovery method.
04 · GO / NO-GO CRITERIA
Define the evidence before testing begins.
The first program is designed around three decision-making outputs—not an open-ended material trial.
Dose-to-recovery curve
Settling, filtration or flotation improvement
Residual removal and cost per processed volume
05 · FROM SAMPLE TO DECISION
A practical application program,
not a bag of powder.
Define
Agree on the function, baseline, constraints and measurable success criteria.
Screen
Select the MW, DDA, purity, dose and physical format that fit the application.
Validate
Test the winning system in the finished formulation, device, process or use environment.
Recommended first request: A charge-density screening set with a bench-scale jar-test protocol.
Start the Sample Brief06 · WHY CHITOSAN
Cationic complexation + matrix control
Protonated amino groups can interact with selected anionic actives, polymers and biological surfaces. MW, DDA, crosslinking and architecture then provide levers for adhesion, protection and release.
There is no universal concentration. Grade and dose are screened against pH, interacting ingredients, process conditions and the target performance profile.
Route-specific purity, residuals, compatibility, stability and regulatory suitability are established for the finished system.